Steven Springmeyer, M.D. has served as Co-Chief Medical Officer since July 2018. Dr. Springmeyer joined Biodesix after the acquisition of Integrated Diagnostics where he served as Chief Medical Officer. Dr. Springmeyer is a board-certified physician in Pulmonary and Critical Care Medicine and spent over 29 years in direct patient care. Dr. Springmeyer founded the University of Washington Pulmonary Section at the Fred Hutchinson Cancer Research Center and was a Clinical Professor of Medicine until 2019.
Dr. Springmeyer was a key contributor in the clinical research and development for the Spiration Valve System, which improves patients' breathing and lung health, specifically in end-stage emphysema patients. His research interests have included diagnostic and therapeutic uses of fiberoptic bronchoscopy and bronchoalveolar lavage, treatment of severe emphysema, and early diagnosis of pulmonary nodules and lung cancer.
Dr. Springmeyer received his doctorate degree from the University of Utah, and he completed his training at the University of Washington. Dr. Springmeyer joined Virginia Mason Medical Center in 1984, where he served as President and Director of Clinical Research at the Virginia Mason Research Center, and co-developed programs in Lung Volume Reduction Surgery and Thoracic Oncology.
Dr. Springmeyer has held many professional membership and leadership positions including the American Thoracic Society; Board Member and Chair of Council of Chapter Representatives, Washington Thoracic Society; President and Board Member, American College of Chest Physician; Fellow, and the American Association of Bronchology and Interventional Pulmonology.